Omalizumab (Xolair) Lyophilized Powder from Germany
Omalizumab is a humanized monoclonal antibody binding IgE for severe asthma treatment. It fits HTS 3002.15.00.11 as a biotech immunological product in measured doses for retail sale.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Validate IgE specificity; declare asthma prophylactic immunological use